Integrative Perspectives on Neurodegeneration and Aging: From Molecular Insights to Therapeutic Strategies

References

1. AlgantriK.R. HamzahM. NasirM. RahmanA. Neuroprotective agents: Implications for parkinson’s disease treatment.Curr. Alzheimer Res.20252263466010.2174/0115672050368080250529075006
   [Google Scholar]
2. ChauhanB.S. SinghY.P. PoeggelerB. SinghS.K. Therapeutic Advances in Alzheimer’s Disease: Integrating natural, semi-synthetic, and synthetic drug strategies.Curr. Alzheimer Res.20252211710.2174/0115672050366727250513061730 40454492
   [Google Scholar]
3. BhaskarR. NarayananK.B. SinghK.K. HanS.S. Mapping the connection between circadian rhythms, metabolism, and neurodegeneration: Exploring therapeutic strategies.Curr. Alzheimer Res.20252267869710.2174/0115672050381989250626071304
   [Google Scholar]
4. SinghA. SethiP. GhoshS. Current status of prevention strategies adapted for Alzheimer’s disease.In: A New Era in Alzheimer’s Research: Pathogenesis, Prevention, and Treatment.United StatesAcademic Press202410.1016/B978‑0‑443‑15540‑6.00004‑5
   [Google Scholar]
5. MishraP.K. GhoshS. SinghK.K. SinhaJ.K. Physical exercise and lifestyle management: Preventive measures for Alzheimer’s disease.In: A New Era in Alzheimer’s Research: Pathogenesis, Prevention, and Treatment.United StatesAcademic Press202410.1016/B978‑0‑443‑15540‑6.00003‑3
   [Google Scholar]
6. SachdevaP. NarayananK.B. SinhaJ.K. Recent advances in drug delivery systems targeting insulin signalling for the treatment of Alzheimer’s Disease.J. Alzheimers Dis.20249841169117910.3233/JAD‑231181 38607755
   [Google Scholar]
7. VashisthK. SharmaS. GhoshS. Immunotherapy in Alzheimer’s Disease: Current status and future directions.J. Alzheimers Dis.2024101s1S23S3910.3233/JAD‑230603 39422934
   [Google Scholar]
8. BanoS. RazaM.A. GhoshS. Emerging therapeutic targets in molecular neuropharmacology for Alzheimer’s Disease.J. Biol. Regul. Homeost. Agents202337115769578410.23812/j.biol.regul.homeost.agents.20233711.553
   [Google Scholar]
9. GhoshS. SachdevaB. SachdevaP. ChaudharyV. RaniG.M. SinhaJ.K. Graphene quantum dots as a potential diagnostic and therapeutic tool for the management of Alzheimer’s disease.Carbon Letters20223261381139410.1007/s42823‑022‑00397‑9
   [Google Scholar]
10. MishraP. MittalA.K. KaloniaH. SIRT1 promotes neuronal fortification in neurodegenerative diseases through attenuation of pathological hallmarks and enhancement of cellular lifespan.Curr. Neuropharmacol.20211971019103710.2174/1570159X18666200729111744 32727328
    [Google Scholar]
11. SethiP. BhaskarR. SinghK.K. Exploring advancements in early detection of Alzheimer’s disease with molecular assays and animal models.Ageing Res. Rev.202410010241110.1016/j.arr.2024.102411 38986845
    [Google Scholar]
12. SethiP. SinghK.K. AmistA.D. Molecular and neuroimaging biomarkers in the diagnosis of Alzheimer’s Disease.In: A New Era in Alzheimer’s Research: Pathogenesis, Prevention, and Treatment.United StatesAcademic Press202410.1016/B978‑0‑443‑15540‑6.00006‑9
    [Google Scholar]
13. GhoshS. DurgvanshiS. AgarwalS. RaghunathM. SinhaJ.K. Current status of drug targets and emerging therapeutic strategies in the management of Alzheimer’s Disease.Curr. Neuropharmacol.202018988390310.2174/1570159X18666200429011823 32348223
    [Google Scholar]